Abstract
Lipopolysaccharides (LPS) are responsible for the immunopharmacologic activities of the endotoxins of gram-negative bacteria. This chapter will discuss their immunopharmacologic actions and the evidence that their actions are mediated in part by cyclic nucleotides. The lipopolysaccharides are ubiquitous in nature and have many immunomodulatory activities. As a result, many immunologists consider them ever present nuisances perturbing their experiments. Clearly in the context of endotoxemia and sepsis the toxicities of endotoxins on the body’s defense systems, including hyperpyrexia, intra-vascular coagulation. reticuloendothelial system (RES) blockade, etc., can be considered host destructive. On the other hand, in the absence of disease, low doses of endotoxins may be considered positive immunoregulatory contributing to more effective host defense. It is possible to envision them as being part of the host defense mechanism. It may be that the nonpathogenic gastrointestinal flora provides a continuous low level of LPS acting as hormonal signals to promote the development and enhance the function of the entire immune system. Endotoxins regulate, either directly or indirectly. almost every phase of the development and function of the natural and specific immune defense systems of the body. They generally promote growth and function of the cell populations involved. They do so at low concentrations (ng/ml), i.e., at concentrations which may be periodically, even regularly. achieved locally and perhaps also systemically. Finally, they appear to act via the cyclic nucleotide pathways by which many of the body’s hormones act and many of the molecules mediating immune function are also thought to act. They, therefore, qualify as messengers acting via receptors and hormonal pathways in physiologically constructive ways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Apte, R., Hertogs, C. and Pluznik, D., 1980, Regulation of lipopolysaccharide-induced granulopoiesis and macrophage formation by spleen cells. J. Immunol. 124: 1223.
Beckner, S. K. and Farrar, W. L., 1986, Interleukin 2 modulation of adenylate cyclase. J. Biol. Chem. 261: 3043.
Betel, I., Martijnse, J. and VandenBerg, K., 1974, Absence of an increase in phospholipid turnover in mitogen-stimulated B lymphocytes. Cell Immunol. 14: 2568.
Bhatnager, R., Schade, U., Rietschel, E. and Decker, K., 1982, Involvement of prostaglandin E and adenosine 3’,5’-monophosphate in lipopolysaccharide-stimulated collagenase release by rat Kupffer cells. Eur. J. Biochem. 125: 125.
Bitensky, M. W., Gorman, R. E. and Thomas, L., 1971, Selective stimulation of epinephrine-responsive adenyl cyclase in mice by endotoxin. Proc. Soc. Biol. Med. 138: 773.
Bomboy, J. D., Jr. and Graber, S. E., 1980, Stimulation of cyclic 3’,5’guanosine monophosphate levels in rat spleen cells by lipopolysaccharide preparations. J. Lab. Clin. Med. 95: 654.
Bonney, R. J. and Humes, J. L., 1984, Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages. J. Leuk. Biol. 35: 1.
Bourne, H. R., Lichtenstein, M., Melmon, K. L., Henney, C. S., Weinstein, Y. and Shearer, G. M., 1974, Modulation of inflammation and immunity by cyclic AMP. Science 184: 19.
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B., 1975, An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. 72: 3666.
Chen, S. S., Tung, J. S., Good, R. A. and Hadden, J. W., 1983, Changes in surface antigens of immature thymocytes under the influence of T cell growth factor and thymic factors. Proc. Natl. Acad. Sci. 80: 5980.
Coffey, R. G. and Hadden, J. W., 1982, Phorbol myristate acetate stimulation of lymphocyte guanylate cyclase and cyclic GMP phosphodiesterase and reduction of adenylate cyclase. Cancer Res. 43: 150.
Coffey, R. G. and Hadden, J. W., 1985, Neurotransmitters, hormones and cyclic nucleotides in lymphocyte regulation. Fed. Proc. 44: 112.
Coffey, R. G. and Hadden, J. W., 1985, Stimulation of lymphocyte guanylate cyclase by arachidonic acid and HETEs, in: “Prostaglandins, Leukotrienes, and Lipoxins,” J. M. Bailey, ed., Plenum Press, New York.
Cohen, Z. A. and Morse, S., 1960, Functional and metabolic properties of polymorphonuclear Leukocytes. II. The influence of a lipopolysaccharide endotoxin. J. Exp. Med. 111: 689.
Cook, J. A., Wise, W. C. and Halushka, P. V., 1981, Thromboxane A2 and prostacyclin production by lipopolysaccharide-stimulated peritoneal macrophages. J. Reticul. Soc. 30: 445.
DesPrez, R. M., 1964, Effects of bacterial endotoxin on rabbit platelets. IV. The divalent ion requirements of endotoxin induced and immunologically induced platelet injury. J. Exp. Med. 124: 971.
Djeu, J., Heinbaugh, J., Holden, H. and Herberman, R., 1979, Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J. Immunol. 122: 175.
Evans, D. J., Jr., Chen, C., Curlin, G. T. and Evans, D. G., 1972, Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nature New Biol. 236: 137.
Fairchild, S. and Cohen, J., 1978, B lymphocyte precursors, J. Immunol. 12: 1227.
Field, M., Graf, L. H., Jr., Laird, W. and Smith, P. L., 1978, Heat-stable enterotoxin of Escherichia coli: In vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc. Natl. Acad. Sci. 75: 2800.
Forbes, J., Nakao, Y. and Smith, R., 1975, T mitogens trigger LPS responsiveness in mouse thymic cells. J. Immunol. 114: 1004.
Freedman, M. H., 1979, Early biochemical events in lymphocyte activation. Cell Immunol. 44: 290.
Gery, I., Kruger, J. and Spiegel, S., 1972, Stimulation of B lymphocytes by endotoxin: Reactions of thymus-deprived mice and karyotypic analysis of dividing cells in mice bearing T6–T6 thymus grafts. J. Immunol. 108: 1088.
Ghezzi, P., Saccardo, B. and Bianchi, M., 1986, Role of reactive oxygen intermediates in the hepatoxicity of endotoxin. Immunopharmacol. 12: 241.
Graff, G., Stephenson, J. H., Glass, D. B., Haddox, M. K. and Goldberg, N. D., 1978, Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxides and fatty acid hydroperoxides. J. Biol. Chem. 253: 7662.
Grugg, S. A. and Harmony, J. A. K., 1985, Increased phosphatidylinositol metabolism is an important but not an obligatory early event in B lymphocyte activation. J. Immunol. 134: 4087.
Hadden, E. M., Sadlik, J. R., Coffey, R. G. and Hadden, J. W., 1982, Effects of phorbol myristate acetate ( PMA) and lymphokine on cyclic GMP levels and proliferation of macrophages. Cancer Res. 42: 3064.
Hadden, J. W., Englard, A., Sadlik, J. R. and Hadden, E. M., 1979, The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro. Int. J. Immunopharmacol. 1: 17.
Hadden, J. W., and Coffey, R. G., 1982, Cyclic nucleotides in mitogen induced lymphocyte proliferation. Immunol. Today 3: 299.
Hadden, J. W., Galy, A., Hadden, E., Touraine, J-L. and Coffey. R., 1986. Cyclic nucleotides in the immunopharmacology of lipopolysaccharide endotoxins, in: “Immunobiology and Immunopharmacology of Bacterial Endotoxins,” A. Szentivanyi, H. Friedman, and A. Nowotny, eds., Plenum Press, New York.
Hadden, J. W., Specter, S., Galy, A., Touraine, J-L. and Hadden, E., 1986, Thymic hormones, interleukins, endotoxin and thymomimetic drugs in T lymphocyte ontogeny, in: “Advances in Immunopharmacology III,” L. Chedid, J. W. Hadden, F. Spreafico, P. Dukor and Willoughby, D., eds., Pergamon Press, Oxford.
Hadden, J. W., Hadden, E. M. and Coffey, R. G., 1987, Interleukin II increases cyclic GMP levels in immature thymocytes and mitogen-primed T lymphocytes. Int. J. Immunopharmacol. 9: 851.
Hadden, J. W., 1987, Transmembrane signals in the activation of T lymphocytes, in: “Mechanisms of Lymphocyte Activation and Immune Regulation,” S. Gupta, W. E. Paul, and A. S. Fauci, eds., Plenum Press, New York.
Hammerling, U., Chin, A. and Scheid, M., 1975, The ontogeny of murine B lymphocytes. J. Immunol. 115: 1425.
Hazeki, K., Mori, Y., Ui, M., 1986, Induction of refractories of cyclic AMP responses to prostaglandin El and epinephrine by prior exposure of guinea pig macrophages to lipopolysaccharide. Arch. Biochem. Biophys. 246: 772.
Hoffman, M., Weiss, O., Koenig, S., Hirst, J. and Oettgen, H., 1975, Suppression and enhancement of the T cell dependent production of anti-body to SRBC in vitro by bacterial lipopolysaccharide. J. Immunol. 114: 738.
Hoffman, M., Galanos, C., Koenig, S. and Oettgen, H., 1977, B cell activation by lipopolysaccharide. J. Exp. Med. 146: 1640.
Katz, S., Kierszenbaum, F. and Waksman, B., 1978, Mechanisms of action of lymphocyte-activating factor. J. Immunol. 121: 2386.
Kurland, J. and Bockman, R., 1978, Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J. Exp. Med. 147: 952.
Largen, M. T. and Votta, B., 1983, Immunocytochemical evidence for 3’,5’-cGMP and 3’,5’-cGMP-dependent protein kinase involvement in lymphocyte proliferation. J. Cyclic Nucleo. Prot. Phosphoryl. Res. 9: 231.
Luderitz, O., Schade, U., Rietschel, E. Th., 1986, Formation and metabolism of leukotriene C4 in macrophages exposed to bacterial lipopolysaccharide. Eur. J. Biochem. 155: 377.
Lui, M-S., Ghosh, S. and Yang, Y., 1983, Change in membrane lipid fluidity induced by phospholipase A activation: A mechanism of endotoxin shock. Life Sci. 33: 1995.
Melchers, F. and Anderson, J., 1974, IgM in bone marrow-derived lymphocytes. Eur. J. Immunol. 4: 181.
Moore, R. N., Urbacek, R., Wahl, L. M. and Mergenhagen, S. E., 1979, Prostaglandin regulation of colony-stimulation factor production by lipopolysaccharide stimulated murine leukocyte. Infect. Immun. 26: 408.
Morris, D. D. and Moore, J. N., 1987, Endotoxin-induced production of thromboxane and prostacyclin by equine peritoneal macrophages. Circ. Shock 23: 295.
Naylor, P. Camp, C. Phillips, A., Thurman, G. and Goldstein, A., 1978, Effect of thymosin and lipopolysaccharide on murine lymphocyte cyclic AMP. J. Immunol. Meth. 20: 143.
Nishizuka, Y., 1984, The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308: 693.
Nowotny, A., 1983, “Beneficial Effects of Endotoxin,” Plenum Press, New York.
Ohara, J. and Watanabe, T., 1982, Microinjection of macromolecules into normal murine lymphocytes by cell fusion techniques. J. Immunol. 128: 1090.
Oppenheim, J., Koopman, W., Wahl, L. and Dougherty, glandin S., 1980, Prosta-produced by activa-murine E2 rather than lymphocyte-activating factor ted human mononuclear cells stimulates increases in cAMP. Cell Immunol. 49: 64.
Ozato, K., Adler, W. and Ebert, J., 1975, Synergism of bacterial lipopolysaccharide and concanavalin A in the activation of thymic lymphocytes. Cell Immunol. 17: 532.
Peavy, D. L. and Fairchild, E. J., 1986, II, Evidence for lipid peroxidation in endotoxin-poisoned mice. Infect. Immun. 52: 613.
Rochette-Egly, C. and Tovey, M. G., 1982, Interferon enhances guanylate cyclase activity in human lymphoma cells. Biochem. Biophysica. Res. Commun. 107: 105.
Russell, S. W., 1986, Involvement of endotoxin in macrophage activation for antitumor immunity, in: “Immunobiology and Immunopharmacology of Bacterial Endotoxins,” A. Szentivanyi, H. Friedman, and A. Nowotny, eds., Plenum Press, New York.
Schade, U. F., 1986, Involvement of lipoxygenases in the activation of mouse macrophages by endotoxin. Biochem. Biophys. Res. Commun. 138: 842.
Scheid, M., Hoffmann, M., Komuro, K., Hemmerlin, U., Abbott, J., Boyse, E., Cohen, G., Hooper, J., Schulof, R. and Goldstein, A., 1973, Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J. Exp. Med. 138: 1027.
Scheid, M. P., Goldstein, G. and Boyse, E. A., 1978, The generation and regulation of lymphocyte populations. J. Exp. Med. 147: 1727.
Schmidtke, J. and Najarian, J., 1975, Synergistic effects on DNA synthesis of phytohemagglutinin or concanavalin A and lipopolysaccharide in human peripheral blood lymphocytes. J. Immunol. 114: 742.
Shenker, B. J. and Gray, I., 1979, Cyclic nucleotide metabolism during lymphocyte transformation. I. Cell. Immunol. 43: 11.
Shenker, B. J. and Gray, I., 1979, Cyclic nucleotide metabolism during lymphocyte transformation. II. Cell. Immunol. 43: 23.
Strauss, B. S. and Stetson, C. A., 1960, Studies on the effect of certain leukocytes of peripheral blood. J. Exp. Med. 112: 653.
Szentivanyi, A., Friedman, H. and Nowotny, A., “Immunobiology and Immunopharmacology of Bacterial Endotoxins,” Plenum Press, New York.
Tsien, W-H., Sampson, M. and Sheppard, H., 1981, The elevation of mouse thymus cell cyclic adenosine monophosphate (cAMP) by lipopolysaccharide. Immunopharm. 3: 253.
VanOosterhout, A. J. M., TenHave, G. A. M. and Nijkamp, F. P., 1986, Endotoxin-induced reduction of ß-adrenoceptor number in guinea pig splenic lymphocyte membranes. Agents Actions 19: 361.
Vogel, S., Hilfiker, M. and Caulfield, M., 1983, Endotoxin-induced T-lymphocyte proliferation. J. Immunol. 130: 1774.
Watson, J., 1975, The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis. J. Exp. Med. 141: 97.
Watson, J., 1976, The involvement of cyclic nucleotide metabolism in the initiation of lymphocyte proliferation induced by mitogens. J. Immunol. 117: 1656.
Watson, J., 1977, Involvement of cyclic nucleotides as intracellular mediators in the induction of antibody synthesis, in: “Comprehensive Immunology,” R. A. Good and S. B. Day, eds., Plenum Press, New York.
Watson, J., Epstein, R. and Cohn, M., 1973, Cyclic nucleotides as intra-cellular mediators of the expression of antigen-sensitive cells. Nature 246: 404.
Weissman, G. and Thomas, L., 1964, On a mechanism of tissue damage by bacterial endotoxins, in: “Bacterial Endotoxin,” M. Landy and W. Braun, eds., Rutgers University Press, New Brunswick.
Wrightman, P. and Raetz, C., 1984, The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide. J. Biol. Chem. 259: 1048.
Williamson, S., Wannemuehler, M., Kirillo, E., Pritchard, D., Michalek, S. and McGhee, J., 1984, LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from bacteroide LPS. J. Immunol. 133: 2294.
Winchurch, R. A., Hilberg, C., Birmingham, W. and Munster, A., 1982, Lipopolysaccharide-induced activation of suppressor cells: reversal by an agent which alters cyclic nucleotide metabolism. Immunol. 45: 147.
Wood, D. and Cameron, P., 1976, Stimulation of the rlease of a B cell activating factor from human monocytes. Cell. Immunol. 21: 133.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hadden, J.W. (1990). Immunopharmacologic Aspects of Lipopolysaccharide Endotoxin Action with Special Reference to Cyclic Nucleotides. In: Friedman, H., Klein, T.W., Nakano, M., Nowotny, A. (eds) Endotoxin. Advances in Experimental Medicine and Biology, vol 256. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5140-6_33
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5140-6_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5142-0
Online ISBN: 978-1-4757-5140-6
eBook Packages: Springer Book Archive